CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

38 hedge funds and large institutions have $6.77M invested in Cellectar Biosciences in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

54% less capital invested

Capital invested by funds: $14.9M → $6.77M (-$8.1M)

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$415K
2
+$334K
3
+$132K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$86.6K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$82.7K

Top Sellers

1
-$4.66M
2
-$523K
3
-$508K
4
GCP
GSA Capital Partners
United Kingdom
-$354K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$268K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$13K
27
$11K
28
$10K
29
$9K
30
$9K
31
$9K
32
$5K
33
$5K
34
$3K
35
$3K
36
$2K
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
1
2